Immunization; Infection
37
5
7
20
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
1 terminated out of 37 trials
95.2%
+8.7% vs benchmark
19%
7 trials in Phase 3/4
20%
4 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (37)
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
Phase 3 Study of BK1310 in Healthy Infants
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Increasing Influenza and Tdap Vaccination of Pregnant Women
Pertussis Immunization During Pregnancy & HIV Infection
Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster
Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
Community Engagement and Conditional Incentives to Accelerate Polio
Leading Advancements in the Uptake of Newborn Community Health
Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers
Safety and Efficacy of NF135 CPS Immunization
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction
Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults